Huntington National Bank’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55 Hold
1
﹤0.01% 2839
2025
Q4
$37 Hold
1
﹤0.01% 3019
2025
Q3
$40 Sell
1
-51
-98% -$1.68K ﹤0.01% 3038
2025
Q2
$1.33K Buy
52
+11
+27% +$240 ﹤0.01% 2295
2025
Q1
$875 Buy
41
+5
+14% +$112 ﹤0.01% 2383
2024
Q4
$756 Buy
+36
New +$833 ﹤0.01% 2435
2023
Q2
Sell
-280
Closed -$4.29K 3810
2023
Q1
$4.29K Buy
+280
New +$4.28K ﹤0.01% 1775
2016
Q2
Sell
-318
Closed -$11K 1623
2016
Q1
$11K Buy
318
+184
+137% +$5.28K ﹤0.01% 1452
2015
Q4
$4K Hold
134
﹤0.01% 1506
2015
Q3
$4K Sell
134
-18
-12% -$657 ﹤0.01% 1560
2015
Q2
$6K Sell
152
-166
-52% -$5.73K ﹤0.01% 1577
2015
Q1
$11K Sell
318
-74
-19% -$2.38K ﹤0.01% 1460
2014
Q4
$12K Buy
+392
New +$10.8K ﹤0.01% 1427

Other funds holding PAHC

Huntington National Bank's PAHC Position: Q1 2026 in Review

Huntington National Bank held its Phibro Animal Health (PAHC) position steady in Q1 2026 at 1 share worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

Huntington National Bank first reported a position in PAHC in Q4 2014 and has held it in 13 quarters since. The position peaked at $12K in Q4 2014. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Huntington National Bank held 1 share of Phibro Animal Health worth $55 as of Q1 2026.
  • Huntington National Bank left its Phibro Animal Health share count unchanged in Q1 2026.
  • Phibro Animal Health made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2839 holding.
  • Huntington National Bank first reported a position in Phibro Animal Health in Q4 2014 and has held it in 13 quarters since.
  • Huntington National Bank's Phibro Animal Health position peaked at $12K in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.